Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness
- Author
- HCPLive.com
- Published
- Fri 07 May 2021
- Episode Link
- https://audioboom.com/posts/7860898
Dr. Paul Yang, of Casey Eye Institute, joins to discuss new ARVO 2021 data supporting the gene therapy for X-linked retinitis pigmentosa.
